Analysis of Diagnostic Value of Cervical Cancer by HPV Test Combined with Thinprep-Cytologic Test
Objective To stuyd the diagnostic value of thinprep-cytologic test(TCT)combined with human papilloma-virus(HPV)test in cervical cancer.Methods 100 patients with suspected cervical precancerous lesions from January 2022 to October 2023 in the Department of Clinical Laboratory,Zibo Maternal and Child Health Hospital New Hospi-tal were selected as study subjects,and HPV detection,TCT and combined detection were performed.The positive rate and diagnostic value of the above single and combined tests were analyzed with the colposcopic results of cervical biopsy as the gold standard.Results Among the 100 subjects,the positive rate of HPV was 20.00%,the positive rate of TCT was 27.00%,and the positive rate of TCT+HPV was 35.00%.The accuracy(96.00%)and sensitivity(91.89%)of TCT+HPV were higher than those of TCT and HPV,and the differences were statistically significant(χ2=8.000,15.457,7.974,18.231,all P＜0.05).Conclusion TCT+HPV has high specificity,sensitivity and accuracy,and has positive significance in the diagnosis of cervical cancer.
Human Papillomavirus test,Thinprep-Cytologic Test detectionCervical cancerCombined diagnosisPositive rateSensitivityAccuracy
NETL
NSTL
万方数据
